Zealand Pharma A/S (ZLDPF) Stock Overview
Explore Zealand Pharma A/Sās financial performance, market position, analyst ratings, and future outlook.
Zealand Pharma A/S (ZLDPF)
Key Financials
Key Financials
Market Cap
3.1B
P/E Ratio
3.12
EPS (TTM)
$14.98
ROE
0.43%
ZLDPF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Zealand Pharma A/S (ZLDPF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 40.79, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $107.46.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 3.12 and a market capitalization of 3.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.